158 related articles for article (PubMed ID: 23067429)
1. I-131-Metaiodobenzylguanidine therapy with allogeneic cord blood stem cell transplantation for recurrent neuroblastoma.
Sato Y; Kurosawa H; Fukushima K; Okuya M; Hagisawa S; Sugita K; Arisaka O; Inaki A; Wakabayashi H; Nakamura A; Fukuoka M; Kayano D; Kinuya S
Ital J Pediatr; 2012 Oct; 38():53. PubMed ID: 23067429
[TBL] [Abstract][Full Text] [Related]
2. Iodine-131-metaiodobenzylguanidine therapy with reduced-intensity allogeneic stem cell transplantation in recurrent neuroblastoma.
Takahashi H; Manabe A; Aoyama C; Kamiya T; Kato I; Takusagawa A; Ogawa C; Ozawa M; Hosoya R; Yokoyama K
Pediatr Blood Cancer; 2008 Mar; 50(3):676-8. PubMed ID: 17243128
[TBL] [Abstract][Full Text] [Related]
3. Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma.
Matthay KK; Yanik G; Messina J; Quach A; Huberty J; Cheng SC; Veatch J; Goldsby R; Brophy P; Kersun LS; Hawkins RA; Maris JM
J Clin Oncol; 2007 Mar; 25(9):1054-60. PubMed ID: 17369569
[TBL] [Abstract][Full Text] [Related]
4. Incorporation of high-dose
Lee JW; Lee S; Cho HW; Ma Y; Yoo KH; Sung KW; Koo HH; Cho EJ; Lee SK; Lim DH
J Hematol Oncol; 2017 May; 10(1):108. PubMed ID: 28511709
[TBL] [Abstract][Full Text] [Related]
5. Feasibility and effectiveness of treatment strategy of tandem high-dose chemotherapy and autologous stem cell transplantation in combination with
Suh JK; Koh KN; Min SY; Kim YS; Kim H; Im HJ; Namgoong JM; Kim DY; Ahn SD; Lee JJ; Seo JJ
Pediatr Transplant; 2020 Mar; 24(2):e13658. PubMed ID: 31960542
[TBL] [Abstract][Full Text] [Related]
6. 131I-MIBG as a first-line treatment in high-risk neuroblastoma patients.
Hoefnagel CA; De Kraker J; Valdés Olmos RA; Voûte PA
Nucl Med Commun; 1994 Sep; 15(9):712-7. PubMed ID: 7816384
[TBL] [Abstract][Full Text] [Related]
7. A comparison of targeting of neuroblastoma with mIBG and anti L1-CAM antibody mAb chCE7: therapeutic efficacy in a neuroblastoma xenograft model and imaging of neuroblastoma patients.
Hoefnagel CA; Rutgers M; Buitenhuis CK; Smets LA; de Kraker J; Meli M; Carrel F; Amstutz H; Schubiger PA; Novak-Hofer I
Eur J Nucl Med; 2001 Mar; 28(3):359-68. PubMed ID: 11315605
[TBL] [Abstract][Full Text] [Related]
8. 131I-MIBG followed by consolidation with busulfan, melphalan and autologous stem cell transplantation for refractory neuroblastoma.
French S; DuBois SG; Horn B; Granger M; Hawkins R; Pass A; Plummer E; Matthay K
Pediatr Blood Cancer; 2013 May; 60(5):879-84. PubMed ID: 23024113
[TBL] [Abstract][Full Text] [Related]
9. High-dose iodine-131-metaiodobenzylguanidine with haploidentical stem cell transplantation and posttransplant immunotherapy in children with relapsed/refractory neuroblastoma.
Toporski J; Garkavij M; Tennvall J; Ora I; Gleisner KS; Dykes JH; Lenhoff S; Juliusson G; Scheding S; Turkiewicz D; Békássy AN
Biol Blood Marrow Transplant; 2009 Sep; 15(9):1077-85. PubMed ID: 19660720
[TBL] [Abstract][Full Text] [Related]
10. [(131)I] and [(125)I] metaiodobenzylguanidine therapy in macroscopic and microscopic tumors: a comparative study in SK-N-SH human neuroblastoma and PC12 rat pheochromocytoma xenografts.
Rutgers M; Buitenhuis CK; van der Valk MA; Hoefnagel CA; Voûte PA; Smets LA
Int J Cancer; 2000 Dec; 90(6):312-25. PubMed ID: 11180134
[TBL] [Abstract][Full Text] [Related]
11. 131I MIBG therapy in neuroblastoma: mechanisms, rationale, and current status.
Tepmongkol S; Heyman S
Med Pediatr Oncol; 1999 Jun; 32(6):427-31; discussion 432. PubMed ID: 10358701
[TBL] [Abstract][Full Text] [Related]
12. Pilot study of iodine-131-metaiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem-cell support for the treatment of neuroblastoma.
Yanik GA; Levine JE; Matthay KK; Sisson JC; Shulkin BL; Shapiro B; Hubers D; Spalding S; Braun T; Ferrara JL; Hutchinson RJ
J Clin Oncol; 2002 Apr; 20(8):2142-9. PubMed ID: 11956276
[TBL] [Abstract][Full Text] [Related]
13. Engraftment after myeloablative doses of 131I-metaiodobenzylguanidine followed by autologous bone marrow transplantation for treatment of refractory neuroblastoma.
Goldberg SS; DeSantes K; Huberty JP; Price D; Hasegawa BH; Reynolds CP; Seeger RC; Hattner R; Matthay KK
Med Pediatr Oncol; 1998 Jun; 30(6):339-46. PubMed ID: 9589082
[TBL] [Abstract][Full Text] [Related]
14. 131I-Metaiodobenzylguanidine conditioning regimen in children with neuroblastoma undergoing stem cell transplantation.
Atas E; Kesik V; Kismet E; Koseoglu V
Pediatr Transplant; 2013 Jun; 17(4):407-8. PubMed ID: 23692603
[No Abstract] [Full Text] [Related]
15. [131I]metaiodobenzylguanidine therapy in advanced neuroblastoma.
Claudiani F; Garaventa A; Bertolazzi L; Villavecchia GP; Cabria M; Scopinaro G; Bestagno M; Guerra P; Canevarollo N; Scielzo G
J Nucl Biol Med (1991); 1991; 35(4):224-7. PubMed ID: 1823823
[TBL] [Abstract][Full Text] [Related]
16. Preoperative [131I]metaiodobenzylguanidine therapy of neuroblastoma at diagnosis ("MIBG de novo").
Hoefnagel CA; de Kraker J; Voûte PA; Valdés Olmos RA
J Nucl Biol Med (1991); 1991; 35(4):248-51. PubMed ID: 1823828
[TBL] [Abstract][Full Text] [Related]
17. [131I]metaiodobenzylguanidine therapy after conventional therapy for neuroblastoma.
Hoefnagel CA; Voûte PA; De Kraker J; Valdés Olmos RA
J Nucl Biol Med (1991); 1991; 35(4):202-6. PubMed ID: 1823819
[TBL] [Abstract][Full Text] [Related]
18. The treatment of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine (131I-MIBG): a comprehensive review of 116 reported patients.
Loh KC; Fitzgerald PA; Matthay KK; Yeo PP; Price DC
J Endocrinol Invest; 1997 Dec; 20(11):648-58. PubMed ID: 9492103
[TBL] [Abstract][Full Text] [Related]
19. Iodine-131-metaiodobenzylguanidine as initial induction therapy in stage 4 neuroblastoma patients over 1 year of age.
de Kraker J; Hoefnagel KA; Verschuur AC; van Eck B; van Santen HM; Caron HN
Eur J Cancer; 2008 Mar; 44(4):551-6. PubMed ID: 18267358
[TBL] [Abstract][Full Text] [Related]
20.
Sugiyama M; Seigo K; Hosoya Y; Iguchi A; Manabe A
Pediatr Int; 2020 Jun; 62(6):746-747. PubMed ID: 32478419
[No Abstract] [Full Text] [Related]
[Next] [New Search]
